Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureHuanpeng Chen, Yujing Ke, Zilong Wu, Ziwei Ou, Nanqi Huang, Zhenyu Lin, Huixin Gao, Xuehu Xu, Lijuan Lu, Zhaofeng Huang, Yingjie Bian
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Understanding the Intersections between Metabolism and Cancer Biology
10.1016/j.cell.2016.12.039 · 2017
Metabolic reprogramming and cancer progression
10.1126/science.aaw5473 · 2020
Cancer metabolism: looking forward
10.1038/s41568-021-00378-6 · 2021
The metabolism of cancer cells during metastasis
10.1038/s41568-020-00320-2 · 2021
The hallmarks of cancer metabolism: Still emerging
10.1016/j.cmet.2022.01.007 · 2022
Metabolic pathway analysis using stable isotopes in patients with cancer
10.1038/s41568-023-00632-z · 2023
Metabolic barriers to cancer immunotherapy
10.1038/s41577-021-00541-y · 2021
Metabolic programming and immune suppression in the tumor microenvironment
10.1016/j.ccell.2023.01.009 · 2023
Metabolism of immune cells in cancer
10.1038/s41568-020-0273-y · 2020
Immunometabolic Interplay in the Tumor Microenvironment
10.1016/j.ccell.2020.09.004 · 2021
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
Metabolic communication in the tumour–immune microenvironment
10.1038/s41556-022-01002-x · 2022
Solute carrier transporters: the metabolic gatekeepers of immune cells
10.1016/j.apsb.2019.12.006 · 2020
A guide to plasma membrane solute carrier proteins
10.1111/febs.15531 · 2021
A structure and evolutionary-based classification of solute carriers
10.1016/j.isci.2022.105096 · 2022
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
10.1016/j.cell.2015.08.016 · 2015
Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-α
10.1016/j.cmet.2023.07.001 · 2023
Cancer SLC43A2 alters T cell methionine metabolism and histone methylation
10.1038/s41586-020-2682-1 · 2020
SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity
10.1038/s41586-023-06299-8 · 2023
Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+ T cells
10.1016/j.cell.2024.03.011 · 2024
Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration
10.1038/s41416-019-0717-x · 2020
Riboflavin (vitamin B-2) and health
10.1093/ajcn/77.6.1352 · 2003
Riboflavin (vitamin B2) and oxidative stress: a review
10.1017/s0007114514000178 · 2014
Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1
10.1152/ajpcell.00019.2008 · 2008
Identification and Functional Characterization of Rat Riboflavin Transporter 2
10.1093/jb/mvn181 · 2009
Identification and Comparative Functional Characterization of a New Human Riboflavin Transporter hRFT3 Expressed in the Brain
10.3945/jn.110.122911 · 2010
SLC52A3, A Brown-Vialetto-van Laere syndrome candidate gene is essential for mouse development, but dispensable for motor neuron differentiation
10.1093/hmg/ddw053 · 2016
The Expression of Riboflavin Transporters in Human Colorectal Cancer
2018
Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
10.3389/fphar.2019.00079 · 2019
Systematic analysis of the role of SLC52A2 in multiple human cancers
2022
Riboflavin transport and metabolism in humans
10.1007/s10545-016-9950-0 · 2016
Riboflavin drives nucleotide biosynthesis and iron-sulfur metabolism to promote acute myeloid leukemia
2025
The assembly of succinate dehydrogenase: a key enzyme in bioenergetics
10.1007/s00018-019-03200-7 · 2019
Succinate dehydrogenase and human diseases: new insights into a well-known enzyme
10.1038/sj.ejhg.5200793 · 2002
Role of Mitochondria in Ferroptosis
10.1016/j.molcel.2018.10.042 · 2019
Mitochondria and ferroptosis
2022
The diversified role of mitochondria in ferroptosis in cancer
2023
Mitochondrial superoxide mediates labile iron level: evidence from Mn-SOD-transgenic mice and heterozygous knockout mice and isolated rat liver mitochondria
10.1016/j.freeradbiomed.2013.06.026 · 2013
The significance, trafficking and determination of labile iron in cytosol, mitochondria and lysosomes
10.1039/c8mt00048d · 2018
Pulling back the mitochondria’s iron curtain
10.1038/s44324-024-00045-y · 2025
Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells
10.1016/j.redox.2022.102324 · 2022
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
10.1038/nprot.2017.016 · doi-reference
limma powers differential expression analyses for RNA-sequencing and microarray studies
10.1093/nar/gkv007 · doi-reference
GSVA: gene set variation analysis for microarray and RNA-seq data
10.1186/1471-2105-14-7 · doi-reference
Dictionary learning for integrative, multimodal and scalable single-cell analysis
10.1038/s41587-023-01767-y · doi-reference
Extending support for mouse data in the Molecular Signatures Database (MSigDB)
10.1038/s41592-023-02014-7 · doi-reference
ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization
10.1093/bioinformatics/btv145 · doi-reference
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
10.1038/nature10730 · doi-reference
Model-based analysis of ChIP-Seq (MACS)
10.1186/gb-2008-9-9-r137 · doi-reference
The Sequence Alignment/Map format and SAMtools
10.1093/bioinformatics/btp352 · doi-reference
Fast gapped-read alignment with Bowtie 2
10.1038/nmeth.1923 · doi-reference
Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads
10.1186/1471-2105-15-182 · doi-reference
Phenotype molding of stromal cells in the lung tumor microenvironment
10.1038/s41591-018-0096-5 · doi-reference
Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer
10.1038/s12276-020-00493-8 · doi-reference
Accumulation of succinate suppresses de novo purine synthesis through succinylation-mediated control of the mitochondrial folate cycle
10.1016/j.molcel.2025.10.002 · doi-reference
Riboflavin intake, MTRR genetic polymorphism (rs1532268) and gastric cancer risk in a Korean population: a case–control study
10.1017/s0007114521001811 · doi-reference
Vitamin B2 intake reduces the risk for colorectal cancer: a dose–response analysis
10.1007/s00394-018-1702-5 · doi-reference
Dietary vitamin B2 intake and breast cancer risk: a systematic review and meta-analysis
10.1007/s00404-016-4278-4 · doi-reference
B Vitamins, Glucoronolactone and the Immune System: Bioavailability, Doses and Efficiency
10.3390/nu16010024 · doi-reference
Riboflavin: The Health Benefits of a Forgotten Natural Vitamin
10.3390/ijms21030950 · doi-reference
Sulfur partitioning from cysteine controls T cell proliferation and effector function
10.1016/j.cell.2026.03.012 · doi-reference
Succinate dehydrogenase/complex II is critical for metabolic and epigenetic regulation of T cell proliferation and inflammation
10.1126/sciimmunol.abm8161 · doi-reference
A Call for Systematic Research on Solute Carriers
10.1016/j.cell.2015.07.022 · doi-reference
SLC transporters as therapeutic targets: emerging opportunities
10.1038/nrd4626 · doi-reference
Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease
10.1124/pr.118.015735 · doi-reference
Nutrient transporters: connecting cancer metabolism to therapeutic opportunities
10.1038/s41388-023-02593-x · doi-reference
Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC
10.1097/hep.0000000000000962 · doi-reference
CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4
10.1016/j.ccell.2022.02.003 · doi-reference
Riboflavin metabolism shapes FSP1-driven ferroptosis resistance
10.1038/s41556-025-01856-x · doi-reference
Vitamin B2 metabolism promotes FSP1 stability to prevent ferroptosis
10.1038/s41594-026-01759-x · doi-reference
Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes
10.1016/j.bbagen.2012.09.018 · doi-reference
FAD-binding site of glutathione reductase
10.1016/0022-2836(82)90177-2 · doi-reference
KDM6 Demethylases and Their Roles in Human Cancers
10.3389/fonc.2021.779918 · doi-reference
Orchestration of H3K27 methylation: mechanisms and therapeutic implication
10.1007/s00018-017-2596-8 · doi-reference
Targeting SLC7A11-mediated cysteine metabolism for the treatment of trastuzumab-resistant HER2-positive breast cancer
10.7554/elife.103953 · doi-reference
HBx facilitates ferroptosis in acute liver failure via EZH2 mediated SLC7A11 suppression
10.1186/s12929-021-00762-2 · doi-reference
Role of nrf2 in oxidative stress and toxicity
10.1146/annurev-pharmtox-011112-140320 · doi-reference
Mitophagy-related regulated cell death: molecular mechanisms and disease implications
10.1038/s41419-024-06804-5 · doi-reference
Iron chelators as mitophagy agents: Potential and limitations
10.1016/j.biopha.2024.117407 · doi-reference
Mdivi-1 alleviates ferroptosis induced by hypoxia combined with propofol in HT22 cells by inhibiting excessive mitophagy
10.1007/s11033-024-09812-y · doi-reference